Ketoconazole inhibits the growth of HCC cells by inhibiting prostaglandin-endoperoxide synthase 2, which activates the accumulation of PINK1 on the mitochondrial membrane and induces HCC cell apoptosis (150, 151). Here, PINK1 is linked to hepatocellular carcinoma.